glp 1 compound side effects Uncommon of GLP-1 Medication GI Adverse Effects of Glucagon-Like
Description
Pfizer has said it expects pills to eventually capture about a third of the obesity drug market, which is predicted to grow to about $130 billion by the end of the decade.
It is prescribed to patients with diabetes
It includes three products
Semaglutide: Tirzepatide is a dual agonist for GLP-1 and GIP receptors
Americans spent an average of $1,514 out of pocket on medical care in 2023, which is 25.3% of Ozempic's annual self-pay cost of $5,988.
